SMD Rise PCL (BKK:SMD100-R) 1-Year Sharpe Ratio: -87.40 (As of Jul. 06, 2026)


BKK:SMD100-R SMD Rise PCL BKK:SMD100-R
60 GF Score
Price ฿5.85
GF Value ฿24.10
! 6 Warning Signs
View Full Analysis

What is SMD Rise PCL 1-Year Sharpe Ratio?

SMD Rise PCL BKK:SMD100-R 60 1-Year Sharpe Ratio is -87.40 as of Jul. 06, 2026. GuruFocus rates BKK:SMD100-R with a GF Score™ of 60/100 and a GF Value™ of ฿24.10. The stock has 6 warning signs investors should review.

The 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk over the past year. As of today (2026-07-06), SMD Rise PCL's 1-Year Sharpe Ratio is -87.40.

SMD Rise PCL  (BKK:SMD100-R) 1-Year Sharpe Ratio Explanation

The 1-Year Sharpe Ratio inidicates the risk-adjusted return of an investment over the past year. It is calculated as the annualized result of the average monthly excess return divided by its standard deviation over the past year. The monthly excess return is the monthly investment return minus the monthly risk-free rate (typically the 10-year Treasury Constant Maturity Rate). If the risk-free rate for a specific region is not available, U.S. data is used by default.

The greater a portfolio's Sharpe Ratio, the better its risk-adjusted performance. A negative Sharpe Ratio means the risk-free rate is greater than the portfolio’s historical or projected return, or else the portfolio's return is expected to be negative.

SMD Rise PCL 1-Year Sharpe Ratio Related Terms

BKK:SMD100-R vs MCK, CAH, COR: 1-Year Sharpe Ratio Comparison

For the Medical Distribution subindustry, SMD Rise PCL's 1-Year Sharpe Ratio, along with its competitors' market caps and 1-Year Sharpe Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

SMD Rise PCL 1-Year Sharpe Ratio vs Medical Distribution Industry

For the Medical Distribution industry and Healthcare sector, SMD Rise PCL's 1-Year Sharpe Ratio distribution charts can be found below:

* The bar in red indicates where SMD Rise PCL's 1-Year Sharpe Ratio falls into.


BKK:SMD100-R
60GF Score
SMD Rise PCL BKK:SMD100-R
1-Year Sharpe Ratio is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

SMD Rise PCL 1-Year Sharpe Ratio Calculation

The 1-Year Sharpe Ratio measures the performance of an investment such as a stock or portfolio compared to a risk-free asset. A stock / portfolio's 1-Year Sharpe Ratio can be calculated by dividing the difference between the one-year returns of the investment and the risk-free rate, by the standard deviation of the investment returns over one year.

Frequently Asked Questions Learn more about 1-Year Sharpe Ratio →
What does a 1-Year Sharpe Ratio of -87.40 mean?
SMD Rise PCL (BKK:SMD100-R) has a 1-Year Sharpe Ratio of -87.40 as of Jul. 06, 2026. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for SMD Rise PCL and its competitors.
Is SMD Rise PCL's 1-Year Sharpe Ratio too high?
SMD Rise PCL's current 1-Year Sharpe Ratio is -87.40. Overall, SMD Rise PCL has a GF Score™ of 60/100, reflecting its overall financial health beyond just this single metric.
How does SMD Rise PCL's 1-Year Sharpe Ratio compare to MCK and CAH?
SMD Rise PCL's 1-Year Sharpe Ratio of -87.40 can be compared against companies in the Medical Distribution industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 1-Year Sharpe Ratio for a Medical Distribution company?
A good 1-Year Sharpe Ratio depends on the Medical Distribution industry context. However, 1-Year Sharpe Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 1-Year Sharpe Ratio mean?
A high 1-Year Sharpe Ratio can signal that a stock is expensive relative to its fundamentals. 1-Year Sharpe Ratio measures the additional return that an investor receives per unit of increase in risk. View historical data for SMD Rise PCL and its competitors. SMD Rise PCL's current 1-Year Sharpe Ratio is -87.40. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SMD Rise PCL stock overvalued right now?
SMD Rise PCL (BKK:SMD100-R) has a current 1-Year Sharpe Ratio of -87.40. The stock's GF Value™ is ฿24.10, compared to a current price of ฿5.85 — trading 75.7% below its estimated fair value. The current 1-Year Sharpe Ratio is -87.40. SMD Rise PCL's overall GF Score™ is 60/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 1-Year Sharpe Ratio calculated?
1-Year Sharpe Ratio is calculated from a company's financial statements. For SMD Rise PCL (BKK:SMD100-R), the current 1-Year Sharpe Ratio is -87.40 as of Jul. 06, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is SMD Rise PCL (BKK:SMD100-R) Overvalued in 2026?

Based on GuruFocus' analysis, SMD Rise PCL stock appears to be undervalued. The current stock price of ฿5.85 is trading 75.7% below its estimated GF Value™ of ฿24.10.

Key valuation signals for BKK:SMD100-R:

  • 1-Year Sharpe Ratio: -87.40
  • GF Value™: ฿24.10 vs. price of ฿5.85 (75.7% below fair value)
  • GF Score™: 60/100 with 6 warning signs

No single metric tells the full story. See the BKK:SMD100-R stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

SMD Rise PCL Business Description

Other Exchanges SMD100:Thailand
Address 222,222/1-2 Moo 1, Rattanathibet Road, West Inn Complex Building, 10th Floor, Bang Rak Yai Subdistrict, Bang Bua Thong District, Nonthaburi Province, Bangkok, THA, 11110
SMD Rise PCL, formerly Saintmed PCL is engaged in the import and distribution of medical devices and equipment, rental services for medical equipment, and providing services related to medical equipment. It operates in Thailand. The Group is engaged in three operating segments: Sale of medical devices and equipment, medical supplies, Services of medical equipment at sleep lab centers and repair services, and Revenue from rental of medical equipment at wellness centers and other services. The Group is managed and operates principally in Thailand.
60GF Score

Get the complete analysis for BKK:SMD100-R

1-Year Sharpe Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

฿5.85
Price
฿24.10
GF Value